These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1924437)

  • 41. DNA content in renal cell carcinoma and its clinical significance.
    Roos G; Ljungberg B
    Eur Urol; 1990; 18 Suppl 2():29-30. PubMed ID: 2226602
    [No Abstract]   [Full Text] [Related]  

  • 42. Next-generation sequencing of urologic cancers: next is now.
    Real FX; Boutros PC; Malats N
    Eur Urol; 2014 Jul; 66(1):4-7. PubMed ID: 24731787
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Renal cell carcinoma in a kidney transplant: allogeneic genome in the tumor justifies organ-preserving surgery.
    Schostak M; Heicappell R; Sauter T; Goessl C; Krause H; Hoyer J; Miller K
    Transplant Proc; 2002 Sep; 34(6):2231-2. PubMed ID: 12270378
    [No Abstract]   [Full Text] [Related]  

  • 44. De Novo Mutations Contribute to the Development of Clear-Cell Renal-Cell Carcinoma in a 5-Year-Old Girl.
    Yang Z; Zhao J; Zhou L; Wang Y; Hao P; Fang Z
    Clin Genitourin Cancer; 2018 Jun; 16(3):e553-e556. PubMed ID: 29551584
    [No Abstract]   [Full Text] [Related]  

  • 45. Association of leucine zipper protein 2 with prognosis and epigenetic modification in patients with renal clear-cell carcinoma.
    Shi X; Li L; Feng D; Wei W
    Asian J Surg; 2023 May; 46(5):1993-1997. PubMed ID: 36379756
    [No Abstract]   [Full Text] [Related]  

  • 46. The Suggested Importance of PBRM1 Mutation in Predicting Postoperative Recurrence of Localized Clear Cell Renal Cell Carcinoma.
    Goldberg H
    Ann Surg Oncol; 2021 Apr; 28(4):1889-1891. PubMed ID: 33554287
    [No Abstract]   [Full Text] [Related]  

  • 47. Prevention, Diagnosis and Treatment of Rhabdomyolysis after Urological Surgery.
    Brede CM; Lane BR
    J Urol; 2016 Feb; 195(2):245-6. PubMed ID: 26585678
    [No Abstract]   [Full Text] [Related]  

  • 48. [Is the UISS score suitable for the postoperative follow-up protocol for kidney cancer?].
    Bouras S
    Prog Urol; 2023 Jan; 33(1):48-49. PubMed ID: 36153221
    [No Abstract]   [Full Text] [Related]  

  • 49. [Clinical significance of Barr bodies in kidney neoplasms].
    Liul'ko AV; Masalygina LS; Biakov SV; Gutnik AI
    Urol Nefrol (Mosk); 1978; (5):60-3. PubMed ID: 705998
    [No Abstract]   [Full Text] [Related]  

  • 50. Nephron-sparing surgery for renal cell carcinoma.
    Tsui KH; van Ophoven A; Shvarts O; Belldegrun A
    Rev Urol; 1999; 1(4):216-25. PubMed ID: 16985800
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multicentricity in renal cell carcinoma.
    Bilen CY; Mahalati K; Ozen H; Aki FT; Ilyas C; Kendi S
    Int Urol Nephrol; 1999; 31(3):295-9. PubMed ID: 10672947
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Tumor involvement of the vena cava in renal cell carcinoma. Surgical technique, results and prognosis].
    Staehler G; Drehmer I; Pomer S
    Urologe A; 1994 Mar; 33(2):116-21. PubMed ID: 8178405
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Conservative surgery of kidney tumors.
    Selli C; Lapini A; Carini M
    Prog Clin Biol Res; 1991; 370():9-17. PubMed ID: 1924484
    [No Abstract]   [Full Text] [Related]  

  • 54. Conservative surgical treatment of renal cell carcinoma. The University of Miami experience.
    Block NL; Ciancio G
    J Fla Med Assoc; 1995 Sep; 82(9):607-11. PubMed ID: 7595342
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Value of DNA analysis for treatment of renal cell carcinoma.
    Ljungberg B; Roos G
    Eur Urol; 1990; 18 Suppl 2():31-2. PubMed ID: 2226603
    [No Abstract]   [Full Text] [Related]  

  • 56. Tumor enucleation of renal cell carcinoma: operative technique, DNA cytometry results, complications.
    Steinbach F; Stöckle M; Riedmiller H; Weingärtner K; Hohenfellner R
    Prog Clin Biol Res; 1991; 370():1-7. PubMed ID: 1924437
    [No Abstract]   [Full Text] [Related]  

  • 57. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
    Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H
    Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.